Obesity resistance of the stearoyl-CoA desaturase-deficient (scd1-/-) mouse results from disruption of the epidermal lipid barrier and adaptive thermoregulation

被引:69
作者
Binczek, Erika
Jenke, Britta
Holz, Barbara
Guenter, Robert Heinz
Thevis, Mario
Stoffel, Wilhelm
机构
[1] Univ Cologne, Lab Mol Neurosci, Ctr Mol Med CMMC, Ctr Biochem,Fac Med, D-50931 Cologne, Germany
[2] DSHS Koln, Inst Biochem, D-50933 Cologne, Germany
关键词
dysregulation of thermogenesis; epidermal lipid barrier breakdown; hypermetabolism; obesity resistance; SCD1; deficiency; VLCFA synthesis;
D O I
10.1515/BC.2007.046
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Targeted deletion of the stearoyl-CoA desaturase 1 gene (scd1) in mouse causes obesity resistance and a severe skin phenotype. Here, we demonstrate that SCD1 deficiency disrupts the epidermal lipid barrier and leads to uncontrolled transepidermal water loss, breakdown of adaptive thermoregulation and cold resistance, as well as a metabolic wasting syndrome. The loss of omega-hydroxylated very long-chain fatty acids (VLCFA) and ceramides substituted with w-hydroxylated VLCFA covalently linked to corneocyte surface proteins leads to the disruption of the epidermal lipid barrier in scd1(-/-) mutants. Artificial occlusion of the skin by topical lipid application largely reconstituted the epidermal barrier and also reversed dysregulation of thermogenesis and cold resistance, as well as the metabolic disturbances. Interestingly, SCD1 deficiency abolished expression of the key transcription factor Lef1, which is essential for interfollicular epidermis, sebaceous glands, and hair follicle development. Finally, the occurrence of SCD1 and a newly described hSCD5 (ACOD4) gene in humans suggests that the scd1(-/-)mouse mutant might be a valuable animal model for the study of human skin diseases associated with epidermal barrier defects.
引用
收藏
页码:405 / 418
页数:14
相关论文
共 27 条
[1]  
ABRAHAM W, 1985, J LIPID RES, V26, P761
[2]   THE FATTY-ACID CHAIN ELONGATION SYSTEM OF MAMMALIAN ENDOPLASMIC-RETICULUM [J].
CINTI, DL ;
COOK, L ;
NAGI, MN ;
SUNEJA, SK .
PROGRESS IN LIPID RESEARCH, 1992, 31 (01) :1-51
[3]  
COHEN P, 2004, SCIENCE, V134, P2455
[4]  
Cohen Paul, 2003, Current Drug Targets - Immune Endocrine and Metabolic Disorders, V3, P271, DOI 10.2174/1568008033340117
[5]  
DasGupta R, 1999, DEVELOPMENT, V126, P4557
[6]   The role of stearoyl-CoA desaturase in the control of metabolism [J].
Dobrzyn, A ;
Ntambi, JM .
PROSTAGLANDINS LEUKOTRIENES AND ESSENTIAL FATTY ACIDS, 2005, 73 (01) :35-41
[7]  
Elias P M, 1998, J Investig Dermatol Symp Proc, V3, P87
[8]  
ELIAS PM, 1988, ANN NY ACAD SCI, V548, P4, DOI 10.1111/j.1749-6632.1988.tb18788.x
[9]  
FEINGOLD KR, 1991, CRIT REV THER DRUG, V8, P193
[10]   Leptin and the regulation of body weight in mammals [J].
Friedman, JM ;
Halaas, JL .
NATURE, 1998, 395 (6704) :763-770